| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2026―Aug―09 |
Development of SARS-CoV-2 papain-like protease inhibitors with a thiadiazole and oxadiazole linker |
Rafaqat Hussain, Hina Sarfraz, Tahir Ali Chohan, Uzma Azam, Umair Khurshid, Shoaib Khan, et al. (+2) Yazeed M. Asiri, Saeed Anwar |
| 2 |
[GO] |
2024―Apr―23 |
Activity profiling of natural and synthetic SARS-Cov-2 inhibitors using molecular docking analysis |
Emmanuel C. Ohaekenyem, Chukwuebuka T. Onyema, Sunday E. Atawodi |
| 3 |
[GO] |
2022―Mar―23 |
Use of Circular Dichroism in the characterization of the fusion protein SARS-CoV-2 S protein (RBD)-hFc |
Ingrid Ruíz, Jose A. Gómez, Laura García |
|
